Longitudinal database for patients with gastroparesis symptoms
Official title: Gastroparesis Outcome Longitudinal Database Enrolled Numerically
Run by University of Louisville · NCT03876288 · Data updated 2026-11-12
This study is tracking patients with gastroparesis symptoms over time to see how their health and quality of life change, regardless of the treatments they receive.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | University of Louisville Academic / other |
| Drugs / interventions | Immunotherapy |
| Locations | 1 site (Louisville, Kentucky) |
| Status | Recruiting |
| Started | January 1, 2013 |
| Main results expected | January 1, 2028 |
| Study ends | January 1, 2028 |
| Registry record updated | April 20, 2026 |
| Trial ID | NCT03876288 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with drug-refractory gastroparesis symptoms and disordered nutrition.
✕Probably not a fit
Patients with anatomic obstruction of the GI tract or psychiatric disorders that hinder assessment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The GOLDEN project is a longitudinal database that tracks patients with symptoms of gastroparesis at the University of Louisville, starting from 2012 and continuing to the present. It includes both current patients and legacy patients from other centers, allowing for comprehensive data collection on symptoms, survival, quality of life, and various health measures over time. The study evaluates outcomes regardless of treatment and stratifies results based on different interventions, including GI neuromodulation and immunotherapy. This extensive data collection aims to provide insights into the management and effects of gastroparesis.
Why it matters
Potential benefit: If successful, this study could enhance understanding of gastroparesis and improve patient management strategies.
How similar studies have gone: Other studies have shown success in tracking outcomes for chronic gastrointestinal conditions, making this approach promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion: * Patients with the symptoms (Sx) of drug refractory gastroparesis * Disordered nutrition by standardized assessment * Ability to assess current symptom status * Ability to measure other medical conditions Exclusion: * Anatomic obstruction of the GI Tract * Pregnancy * Inability of patient or guardian to sign informed consent, if needed * Psychiatric disorders precluding assessment and treatment of the patient's GI condition
Where it's running
-
University of Louisville
Louisville, Kentucky, United States Recruiting
Study contacts
- Principal investigator: Thomas Abell, MD — University of Louisville
- Study coordinator: Thomas Abell, MD
- Email: thomas.abell@louisville.edu
- Phone: (502)852-6991
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gastric-focused ultrasound to see if it changes stomach activity and symptoms
This study tests whether noninvasive stomach-focused ultrasound can alter post-meal stomach electrical activity and symptoms in adults with gastroparesis or delayed gastric emptying, using a sham control in a crossover design.
-
Gastric emptying and feeding tolerance in ICU patients by vasopressor dose
This study tests whether vasopressor dose affects how well stomach contents empty during tube feeding in critically ill patients.
-
Virtual poetry workshops to boost well-being for people with digestive symptoms
This study tests whether participating in online poetry workshops can improve emotional well-being for adults with chronic digestive symptoms and anxiety or depression.
-
Risk prediction for gastric retention during sedated gastroscopy
This study will test a simple grading system and prediction model to see if clinicians can identify which adults are likely to have significant stomach contents before sedated gastroscopy.
-
Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients
This study tests whether using Body Surface Gastric Mapping can help predict which medications will help people with gastroparesis or functional dyspepsia see improvement.
-
Using Growth Hormone to Treat Gastroparesis
This study is testing if Growth Hormone can help people with gastroparesis feel better when other treatments haven't worked.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.